SCHEMBL4149982

SCHEMBL4149982

CN(C(=O)NC(=O)c1c(Cl)cccc1Cl)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RORC P51449 4/20 0.38
TLR7 Q9NYK1 4/20 0.37
GAA P10253 7/20 0.36
MAPT P10636 2/20 0.34
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TLR8 Q9NR97 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK1 P28482 1/20 0.34
POLB P06746 1/20 0.34
LMNA P02545 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
RORA P35398 1/20 0.33
RORB Q92753 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4154004 0.96 TLR7 (0.42) RORCTLR7GAAMAPTRAB9A
SCHEMBL4158996 0.90 TRPA1 (0.34) RORCTLR7MAPTRAB9ANPC1
SCHEMBL4637596 0.89 TAS1R3 (0.38) RORC
SCHEMBL4150976 0.88 MEN1 (0.39) RORCTLR7GAAMAPTRAB9A
SCHEMBL4154057 0.86 TLR7 (0.40) RORCTLR7GAAMAPTRAB9A
SCHEMBL4155015 0.86 TLR7 (0.40) RORCTLR7GAAMAPTRAB9A
SCHEMBL4636792 0.85 CYP11B1 (0.35) MAPTMAPK1LMNA
SCHEMBL5314173 0.84 KDM4E (0.35) RORCTLR7GAARAB9ATLR8
SCHEMBL4154082 0.83 RORC (0.43) RORCTLR7GAAMAPTRAB9A
SCHEMBL4637507 0.83 RXFP1 (0.35) MAPTNPC1ALDH1A1MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 RORC 4448/4885TLR7 905/4885GAA 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.